TransDigm Group Incorporated (NYSE:TDG – Get Free Report) COO Joel Reiss sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $1,375.89, for a total transaction of $4,127,670.00. Following the completion of the sale, the chief operating officer now owns 3,600 shares of the company’s stock, valued at $4,953,204. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Joel Reiss also recently made the following trade(s):
- On Monday, July 15th, Joel Reiss sold 3,000 shares of TransDigm Group stock. The stock was sold at an average price of $1,241.60, for a total transaction of $3,724,800.00.
TransDigm Group Stock Performance
Shares of TDG stock opened at $1,388.25 on Friday. TransDigm Group Incorporated has a one year low of $802.46 and a one year high of $1,400.63. The company’s 50-day moving average is $1,290.70 and its 200 day moving average is $1,273.34. The company has a market capitalization of $77.89 billion, a price-to-earnings ratio of 55.07, a price-to-earnings-growth ratio of 2.16 and a beta of 1.42.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on TDG. Bank of America boosted their price objective on shares of TransDigm Group from $1,310.00 to $1,460.00 and gave the stock a “buy” rating in a report on Wednesday, May 29th. Morgan Stanley upped their price objective on shares of TransDigm Group from $1,550.00 to $1,575.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Northcoast Research assumed coverage on shares of TransDigm Group in a report on Thursday, August 1st. They issued a “neutral” rating for the company. StockNews.com lowered shares of TransDigm Group from a “buy” rating to a “hold” rating in a report on Monday, August 5th. Finally, KeyCorp upped their price objective on shares of TransDigm Group from $1,325.00 to $1,440.00 and gave the stock an “overweight” rating in a report on Tuesday, May 28th. Eight equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, TransDigm Group presently has an average rating of “Moderate Buy” and a consensus target price of $1,438.24.
Read Our Latest Stock Report on TransDigm Group
Hedge Funds Weigh In On TransDigm Group
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Fortitude Family Office LLC lifted its stake in TransDigm Group by 283.3% during the 2nd quarter. Fortitude Family Office LLC now owns 23 shares of the aerospace company’s stock valued at $29,000 after acquiring an additional 17 shares during the period. ORG Partners LLC bought a new position in TransDigm Group during the 1st quarter valued at about $30,000. Meeder Asset Management Inc. lifted its stake in TransDigm Group by 275.0% during the 2nd quarter. Meeder Asset Management Inc. now owns 30 shares of the aerospace company’s stock valued at $38,000 after acquiring an additional 22 shares during the period. Central Pacific Bank Trust Division bought a new position in TransDigm Group during the 1st quarter valued at about $39,000. Finally, Hershey Financial Advisers LLC bought a new position in TransDigm Group during the 2nd quarter valued at about $41,000. Institutional investors own 95.78% of the company’s stock.
TransDigm Group Company Profile
TransDigm Group Incorporated designs, produces, and supplies aircraft components in the United States and internationally. The Power & Control segment offers mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, specialized pumps and valves, power conditioning devices, specialized AC/DC electric motors and generators, batteries and chargers, databus and power controls, sensor products, switches and relay panels, hoists, winches and lifting devices, and cargo loading and handling systems.
Read More
- Five stocks we like better than TransDigm Group
- Using the MarketBeat Stock Split Calculator
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- Upcoming IPO Stock Lockup Period, Explained
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Dividend Payout Ratio Calculator
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for TransDigm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransDigm Group and related companies with MarketBeat.com's FREE daily email newsletter.